Real-life experience of ceritinib in crizotinib-pretreated ALK+ advanced non-small cell lung cancer patients.
Cadranel J, Cortot AB, Lena H, Mennecier B, Do P, Dansin E, Mazieres J, Chouaid C, Perol M, Barlesi F, Robinet G, Friard S, Thiberville L, Audigier-Valette C, Vergnenegre A, Westeel V, Slimane K, Buturuga A, Moro-Sibilot D, Besse B.
Cadranel J, et al. Among authors: lena h.
ERJ Open Res. 2018 Feb 13;4(1):00058-2017. doi: 10.1183/23120541.00058-2017. eCollection 2018 Jan.
ERJ Open Res. 2018.
PMID: 29450203
Free PMC article.